

Cover Story
Conversation with The Cancer Letter
Next week, NCI will announce its plans for surviving on an austere budget given to it by Congress as fiscal year 2024 approaches the six-month mark.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- ACOG says it will no longer accept federal funding
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - The Med Student’s Memo – Research Concerns
- ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers